![The Original Shark From 'Shark Tank,' Kevin Harrington, Is Ready To Take Pitches Onto the Blockchain The Original Shark From 'Shark Tank,' Kevin Harrington, Is Ready To Take Pitches Onto the Blockchain](https://imageio.forbes.com/blogs-images/andrewrossow/files/2018/04/Kevin-Harrington-0029-AAA_preview-1200x1799.jpg?format=jpg&width=960)
The Original Shark From 'Shark Tank,' Kevin Harrington, Is Ready To Take Pitches Onto the Blockchain
![The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer. The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.](https://pbs.twimg.com/media/Fd0_KuNaEAEhWJ5.png)
The ICR on Twitter: "Watch Professor Kevin Harrington on @BBCLondonNews as he shares more on how a modified version of the herpes virus could offer hope for some people with advanced #Cancer.
![Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY](https://embed-ssl.wistia.com/deliveries/a43b9d4a477e79a284fe2ef2d33f001b.jpg?image_crop_resized=640x360)
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
![ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London](https://d1ijoxngr27nfi.cloudfront.net/images/default-source/default-album/icr-rmh-clarivate-highly-cited-researchers-2021-2-945x532.tmb-0945x532.jpg?sfvrsn=3d922b69_1)
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
![World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology](https://www.chrisnutting-oncology.co.uk/cms/wp-content/uploads/2022/01/royalmarsden_67975358223_0-500x333.jpeg)
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
![The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program](https://pbs.twimg.com/media/DVf9BssW0AAWu7r.jpg)
The ICR on Twitter: "Professors Kevin Harrington and Alan Melcher (ICR + @royalmarsdenNHS) featured earlier in a @BBCr4today segment on #immunotherapy. In the UK you can still listen to today's live program
The Institute of Cancer Research - From left to right: Professor Kristian Helin, Professor Kevin Harrington, Dr Julia Murray and Dr Ben O'Leary. | Facebook
![Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile](https://i1.rgstatic.net/ii/profile.image/556535446872065-1509699798223_Q512/Kevin-Harrington-2.jpg)
Kevin HARRINGTON | Institute of Cancer Research, London | Division of Radiotherapy and Imaging | Research profile
![The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of The ICR on Twitter: "We were delighted to welcome @JonAshworth (MP & Shadow Health Secretary) to visit us today with @CRUK_Policy to meet Professor Kevin Harrington and team. Jon saw some of](https://pbs.twimg.com/media/DtFiul6XgAAgVaL.jpg:large)